Concepedia
Statistics
Publications
22
Citations
1.9K
H-Index
20
Active since
1996
Affiliations
Knopp Biosciences (United States)(Current)
UPMC Hillman Cancer Center
University of Pittsburgh
Neurological Surgery
Columbia University Irving Medical Center
Michael Bozik is an author at Knopp Biosciences (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
1996–2023
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit Cudkowicz, Leonard H. van den Berg, Jeremy M. Shefner et al. · The Lancet Neurology · 2013 · 235 citations
Medicine, Neurology, Pharmacology +8
Survival Benefit of Stereotactic Radiosurgery for Patients with Malignant Glial Neoplasms
Douglas Kondziolka, John C. Flíckinger, David J. Bissonette et al. · Neurosurgery · 1997 · 226 citations
Medicine, Neurosurgery, Surgery +16
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Merit Cudkowicz, Michael Bozik, Evan W. Ingersoll et al. · Nature Medicine · 2011 · 179 citations
Life Sciences, Neuroscience, Pharmacology +11
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
Susan M. Chang, John G. Kuhn, Jinee Rizzo et al. · Journal of Clinical Oncology · 1998 · 166 citations
Medicine, Oncology, Pharmacology +17
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size
Tanya M. Laidlaw, Calman Prussin, Reynold A. Panettieri et al. · The Laryngoscope · 2018 · 114 citations
Medicine, Otolaryngology, Pharmacotherapy +16
1–5 of 22